The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer

NCT05550415 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer
Chemotherapy Effect
Simvastatin Adverse Reaction

Interventions

DRUG: Simvastatin 40mg
DRUG: Placebo

Sponsor

Indonesia University